← Back to Search

Lung Cancer Screening Recommended for Breast Cancer

N/A

Waitlist Available

Led By Vanessa Diaz, MD

Research Sponsored by Medical University of South Carolina

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up duration of the study, a total five years.

Awards & highlights

Study Summary

This trial is testing a new tool to see if it can help doctors better predict which patients are at risk of not getting recommended cancer screenings. The goal is to improve shared decision-making between patients and doctors to increase the rate of recommended cancer screenings.

Eligible Conditions

Breast Cancer
Colorectal Cancer
Lung Cancer

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ duration of the study, a total of five years.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~duration of the study, a total of five years.

This trial's timeline: 3 weeks for screening, Varies for treatment, and duration of the study, a total of five years. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Rate of successful completion of breast cancer screening noted via electronic health record having mammogram result for the patient.

Rate of successful completion of colorectal cancer screening noted via electronic health record having colonoscopy, fecal occult blood, or non invasive screening option result for the patient.

Rate of successful completion of lung cancer screening noted via electronic health record having low dose computed tomography of the chest result for the patient.

Secondary outcome measures

Average score of clinician experience and satisfaction as assessed via Likert scale survey.

Average score of patient experience and satisfaction as assessed via Likert scale survey.

Trial Design

3Treatment groups

Experimental Treatment

Group I: Lung Cancer Screening RecommendedExperimental Treatment1 Intervention

The USPSTF recommends annual screening for lung cancer with low-dose computed tomography (LDCT) in adults ages 50 to 80 years who have a 20 pack-year smoking history and currently smoke or have quit within the past 15 years.

Group II: Colorectal Cancer Screening RecommendedExperimental Treatment1 Intervention

The USPSTF recommends screening for colorectal cancer starting at age 50 years and continuing until age 75 years.

Group III: Breast Cancer Screening RecommendedExperimental Treatment1 Intervention

The USPSTF recommends biennial screening mammography for women aged 50 to 74 years.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Medical University of South CarolinaLead Sponsor

932 Previous Clinical Trials

7,394,260 Total Patients Enrolled

10 Trials studying Breast Cancer

649 Patients Enrolled for Breast Cancer

National Institute on Aging (NIA)NIH

1,668 Previous Clinical Trials

28,005,064 Total Patients Enrolled

13 Trials studying Breast Cancer

40,449 Patients Enrolled for Breast Cancer

Vanessa Diaz, MDPrincipal InvestigatorMedical University of South Carolina

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who is eligible to enroll in this clinical trial?

"This study is looking for breast cancer patients aged 50-80. A total of 22497 patients are needed for the trial."

Answered by AI

Can new participants join this clinical trial at this time?

"According to the listing on clinicaltrials.gov, this particular trial is not currently recruiting patients. It was originally posted on January 4th, 2022 and was last updated on March 22nd, 2022. Although this trial is not looking for patients right now, there are 2805 other trials that are."

Answered by AI

Does this research study allow patients who are octogenarians to enroll?

"To qualify for this particular clinical trial, applicants must be between the ages of 50 and 80. Out of the 2721 trials available, 100 of them are for people under the age of 18."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Technology-Based Cancer Screening Intervention

Vanessa Diaz 2022. "Technology-Based Cancer Screening Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04535492.